Healthy Controls
94
25
26
41
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
4 terminated out of 94 trials
91.1%
+4.6% vs benchmark
9%
8 trials in Phase 3/4
20%
8 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 41 completed trials
Clinical Trials (94)
A Repository to Study Host-Microbiome Interactions in Health and Disease
Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls
Identification of a Safe and Non-Psychedelic Dose of Psilocybin
Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)
Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?
Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers
Exploring the Genetics of Schizophrenia in Manitoba
Intranasal Insulin and Olanzapine Study in Healthy Volunteers
A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome
Temporal Interference Stimulation for Social Cognition
Decoding Emotional Dynamics in Bipolar Disorder
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?
Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease
Acute Effect of Graded Motor Imagery on Ankle Rehabilitation: A Pilot Study
Measuring the Healthy Pediatric Inflammatory Response to Vaccination.
PET Imaging Evaluation of [11C]SY08
Moral Reasoning Intervention on Moral Justification Abilities